Endo Pharmaceuticals Inc.
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin
Published in Pharma Law Weekly, July 21st, 2009
Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (NASDAQ: ENDP) jointly announced that Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin(TM) in the U.S. with an option for global rights. Urocidin is a patented formulation of Mycobacterial Cell Wall-DNA Complex (MCC) developed by Bioniche for the treatment of non-muscle-invasive bladder cancer that is currently undergoing Phase III clinical testing.
Under the agreement signed by both companies, Endo will pay Bioniche an up-front cash payment of $20M USD and the potential for up to $110M USD in additional payments linked to the achievement of future clinical, regulatory,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2009-07-21)
More Articles from Pharma Law Weekly
- American Civil Liberties Union
ACLU Seeks End To Censorship of Religious Material By Virginia Jail - American Federation of Government Employees
TSA Union Thanks Lawmakers for Supporting H.R. 1881 - American Hospital Association
Economy Forces Most Wired Hospitals to Look Closely at IT Spending - Americans United for Life
AUL President to Senate Judiciary Committee: Ask Top 10 Questions to Judge Sotomayor - AMN Healthcare
Leading Nursing Web site, NurseZone.com Wins Award for Journalism Excellence - AmWINS Group Benefits
Six Ways to Fix the American Healthcare System - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
